Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 HLA class I alleles of LCL 721 and 174 x CEM.T2 (T2).

Literature DB >> 7871529

HLA class I alleles of LCL 721 and 174 x CEM.T2 (T2).

A Steinle¹, D J Schendel.

Abstract

Mesh：

Year: 1994 PMID： 7871529 DOI： 10.1111/j.1399-0039.1994.tb02394.x

Source DB: PubMed Journal: Tissue Antigens ISSN： 0001-2815

Keyword Cloud
Cited

× No keyword cloud information.

8 in total

1. Backbone Modifications of HLA-A2-Restricted Antigens Induce Diverse Binding and T Cell Activation Outcomes.

Authors: Ruslan Gibadullin; Caleb J Randall; John Sidney; Alessandro Sette; Samuel H Gellman
Journal: J Am Chem Soc Date: 2021-04-21 Impact factor: 15.419

2. HLA-Cw*0102-restricted HIV-1 p24 epitope variants can modulate the binding of the inhibitory KIR2DL2 receptor and primary NK cell function.

Authors: Lena Fadda; Christian Körner; Swati Kumar; Nienke H van Teijlingen; Alicja Piechocka-Trocha; Mary Carrington; Marcus Altfeld
Journal: PLoS Pathog Date: 2012-07-12 Impact factor: 6.823

3. Expression of HLA-C molecules confers target cell resistance to some non-major histocompatibility complex-restricted T cells in a manner analogous to allospecific natural killer cells.

Authors: C S Falk; A Steinle; D J Schendel
Journal: J Exp Med Date: 1995-10-01 Impact factor: 14.307

4. Discrimination Between Human Leukocyte Antigen Class I-Bound and Co-Purified HIV-Derived Peptides in Immunopeptidomics Workflows.

Authors: Thomas Partridge; Annalisa Nicastri; Anna E Kliszczak; Louis-Marie Yindom; Benedikt M Kessler; Nicola Ternette; Persephone Borrow
Journal: Front Immunol Date: 2018-04-27 Impact factor: 7.561

HLA class I alleles of LCL 721 and 174 x CEM.T2 (T2).

1. Backbone Modifications of HLA-A2-Restricted Antigens Induce Diverse Binding and T Cell Activation Outcomes.

2. HLA-Cw*0102-restricted HIV-1 p24 epitope variants can modulate the binding of the inhibitory KIR2DL2 receptor and primary NK cell function.

3. Expression of HLA-C molecules confers target cell resistance to some non-major histocompatibility complex-restricted T cells in a manner analogous to allospecific natural killer cells.

4. Discrimination Between Human Leukocyte Antigen Class I-Bound and Co-Purified HIV-Derived Peptides in Immunopeptidomics Workflows.

5. De-risking clinical trial failure through mechanistic simulation.

6. The diversity of the HLA-E-restricted peptide repertoire explains the immunological impact of the Arg107Gly mismatch.

7. Epstein-Barr virus peptides derived from latent cycle proteins alter NKG2A + NK cell effector function.

8. Identification of HLA-A2 restricted CD8⁺ T cell epitopes in SARS-CoV-2 structural proteins.